Proteolysis targeting chimeras (PROTACs) are bifunctional molecules that induce selective protein degradation by linking an E3 ubiquitin ligase enzyme to a target protein. This approach allows scope for targeting "undruggable" proteins, and several PROTACs have reached the stage of clinical candidates. However, the roles of cellular transmembrane transporters in PROTAC uptake and efflux remain underexplored. Here, we utilized transporter-focused genetic screens to identify the ATP-binding cassette transporter ABCC1/MRP1 as a key PROTAC resistance factor. Unlike the previously identified inducible PROTAC exporter ABCB1/MDR1, ABCC1 is highly expressed among cancers of various origins and constitutively restricts PROTAC bioavailability. Moreover, in a genome-wide PROTAC resistance screen, we identified candidates involved in processes such as ubiquitination, mTOR signaling, and apoptosis as genetic factors involved in PROTAC resistance. In summary, our findings reveal ABCC1 as a crucial constitutively active efflux pump limiting PROTAC efficacy in various cancer cells, offering insights for overcoming drug resistance.
Pubmed ID: 39755121 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets BRD3 antibody [2088C3a]
View all literature mentionsThis polyclonal targets SMARCA2 antibody produced in rabbit
View all literature mentionsThis monoclonal targets alpha Tubulin antibody [DM1A] - Loading Control
View all literature mentionsThis unknown targets FAK
View all literature mentionsThis monoclonal targets BRD2
View all literature mentionsThis unknown targets PBRM1
View all literature mentionsThis monoclonal targets Human
View all literature mentionsThis monoclonal targets Brd4 antibody [EPR5150(2)]
View all literature mentionsThis monoclonal targets BRG1 antibody [EPR3912]
View all literature mentionsThis monoclonal targets Human ABCC1
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsCell line Huh-7 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line HAP1 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line MDA-MB-468 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line LS180 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsView all literature mentions
Cell line 1321N1 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line HCT 116 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line SK-MEL-28 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsView all literature mentions
Cell line MDA-MB-468 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line 1321N1 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line HCT 116 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line Huh-7 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line SK-MEL-28 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line HAP1 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line LS180 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsView all literature mentions